| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Biotechnology (IBB) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Biotechnology sector is very positive (overall 1.7, positive 2.2, negative -0.5) on 20251025. The forces of Price Level (2), Option Speculation (1.5), Broad Market Trend (0.4), Sector Price Trend (0.3), Sentiment towards Fundamentals (0.1), and Valuation Sentiment (-1) will drive up the price. The forces of and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on IBB trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-25 | 0% | 0% | 0.3 | 0.3 | 0.1 | 0 | ||||
| 2025-10-24 | 0% | 0% | 155.16 | 76 | 0.38% | 0.33% | 0.3 | 0.3 | 0.1 | 7 |
| 2025-10-23 | 0% | 0% | 154.58 | 73 | 0.43% | 0.13% | 0.5 | 0.2 | 0.3 | 0 |
| 2025-10-22 | 0% | 0% | 153.92 | 71 | -1.35% | 0.13% | 0.4 | 0.2 | 0.5 | 7 |
| 2025-10-21 | 0% | 0% | 156.03 | 84 | -0.29% | 0.39% | 1 | 0.5 | 1.5 | 0 |
| 2025-10-20 | 0% | 0% | 156.49 | 90 | 1.49% | 0.4% | 1.6 | 0.9 | 2.7 | 7 |
| 2025-10-19 | 0% | 0% | 1.8 | 0.7 | 3 | 0 | ||||
| 2025-10-18 | 0% | 0% | 1.8 | 0.7 | 2.9 | 0 | ||||
| 2025-10-17 | 0% | 0% | 154.19 | 82 | 0.5% | 0.2% | 1.8 | 0.7 | 2.9 | 5 |
| 2025-10-16 | 0% | 0% | 153.42 | 82 | 0.02% | 0.26% | 1.2 | 0.3 | 3.2 | 7 |
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (7) Eli Lilly To Acquire Adverum Biotechnologies In Deal Worth Up To $12.47 Per Share Eli Lilly and Company (LLY) on Friday said it has agreed to acquire Adverum Biotechnologies, Inc. (ADVM) in a transaction valued at up to $12.47 per share. Under the terms of the agreement, Lilly will launch a tender offer to purchase all outstanding Adverum shares for $3. (https://www.rttnews.com/) Fri. Oct 24, 2025 | |
| 2 (7) Biogen's Immunology Pipeline Has Long-Term Potential: Analyst Biogen gains exclusive rights to Vanqua's oral C5aR1 antagonist, boosting its immunology pipeline with potential across multiple immune diseases. (https://www.benzinga.com/) Fri. Oct 24, 2025 | |
| 3 (7) Lilly to Buy Adverum in Bet on Gene Therapy for Eye Disease Eli Lilly & Co. agreed to buy Adverum Biotechnologies Inc., a company working to treat blindness, in a deal that ultimately could be worth $261.7 million as it continues a push into gene therapies. (https://www.bloomberg.com/) Fri. Oct 24, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA